(1)
Buchappa, G.; Vijay Kumar, P. S.; Prasad, K. D.; Aparna, P. Scalable and Impurity-Free Process for Dasatinib: Src and BCR-Abl Inhibitor. ajc 2018, 30, 1621-1628.